# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-056304
Filing Date
2024-05-09
Accepted
2024-05-09 08:15:34
Documents
67
Period of Report
2024-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | iron-20240331.htm iXBRL | 10-Q | 1699111
2 | EX-31.1 | iron-ex31_1.htm | EX-31.1 | 14815
3 | EX-31.2 | iron-ex31_2.htm | EX-31.2 | 14523
4 | EX-32.1 | iron-ex32_1.htm | EX-32.1 | 8531
| Complete submission text file | 0000950170-24-056304.txt |  | 7209125

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | iron-20240331.xsd | EX-101.SCH | 1686866
71 | EXTRACTED XBRL INSTANCE DOCUMENT | iron-20240331_htm.xml | XML | 762793

Mailing Address 321 ARSENAL STREET, SUITE 101 WATERTOWN MA 02472
Business Address 321 ARSENAL STREET, SUITE 101 WATERTOWN MA 02472 (617) 674-9274
Disc Medicine, Inc. (Filer) CIK: 0001816736 (see all company filings)

EIN.: 851613057 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39438 | Film No.: 24928719
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)